The Latest Breaking News from FDA

The biotech industry is well poised to flourish, buoyed by its commitment to innovation and potential for groundbreaking discoveries. Thus, investing in the shares of three fundamentally solid biotech companies, Foghorn Therapeutics (FHTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD), might be prudent. Continue reading….

A new study suggests a promising blood test that could diagnose Alzheimer's disease accurately and early, potentially revolutionizing dementia care.

Bovine colostrum supplements are taking over, but the evidence for some claims is lacking

It's been FDA approved as of yesterday

In this informative response, Governor Haley discusses the potential reclassification of marijuana as well as the importance of allowing states to decide i...

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

Experts warn against the risks of illegitimately obtained Ozempic and Wegovy

The FDA is holding potential Sanfilippo syndrome therapies to an impossible and inhumane standard

Two sleep doctors answer everything you need to know about melatonin gummies, including the side effects, how long they last and how many you should take.